99mTc-HYNIC-TOC scintigraphy in patients with differentiated thyroid carcinoma and negative iodine whole body scan.

被引：0
|
作者：
Czepczynski, R. [1 ]
Matysiak-Grzes, M. [1 ]
Gryczynska, M. [1 ]
Baczyk, M. [1 ]
Sowinski, J. [1 ]
机构：
[1] Karol Marcinkowski Univ Med Sci, Poznan, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [31] Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy:: Importance of 99mTc mibi scan combined with high resolution neck ultrasonography
    Casara, D
    Rubello, D
    Saladini, G
    Mazzarotto, R
    Sotti, G
    Tomasella, G
    Pelizzo, MR
    TUMORI, 1999, 85 (02) : 122 - 127
  • [32] Effective detection of the origin which cause tumor-induced osteomalacia (TIO) by [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) scintigraphy
    Jing, Hongli
    Li, Fang
    Zhuang, Hongming
    Chen, Libo
    Du, Yanrong
    Long, Mingqing
    Ba, Jiantao
    Tian, Jian
    Wang, Zhenghua
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [33] Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan
    Baudin, E
    Schlumberger, M
    Lumbroso, J
    Travagli, JP
    Caillou, B
    Parmentier, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07): : 2541 - 2544
  • [34] 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans
    Gabriel, M
    Froehlich, F
    Decristoforo, C
    Ensinger, C
    Donnemiller, E
    von Guggenberg, E
    Heute, D
    Moncayo, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) : 330 - 341
  • [35] 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans
    Michael Gabriel
    Franz Froehlich
    Clemens Decristoforo
    Christian Ensinger
    Eveline Donnemiller
    Elisabeth von Guggenberg
    Dirk Heute
    Roy Moncayo
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 330 - 341
  • [36] Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan
    Saghari, Mohsen
    Gholamrezanezhad, Ali
    Mirpour, Sahar
    Eftekhari, Mohammad
    Takavar, Abbas
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Beiki, Davood
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (07) : 567 - 572
  • [37] Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma
    Shinohara, Shogo
    Kikuchi, Masahiro
    Suehiro, Atsushi
    Kishimoto, Ippei
    Harada, Hiroyuki
    Hino, Megumu
    Ishihara, Takashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 427 - 432
  • [38] Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC
    Luo, Yaping
    Wang, Ling
    Pan, Qingqing
    Ma, Yanru
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (07) : 551 - 552
  • [39] 99mTc-HYNIC-TOC (99mTc-Hydrazinonicotinyl-Tyr3-Octreotide) Scintigraphy Identifying Two Separate Causative Tumors in a Patient With Tumor-Induced Osteomalacia (TIO)
    Jing, Hongli
    Li, Fang
    Zhong, Dingrong
    Zhuang, Hongming
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (08) : 664 - 667
  • [40] A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT
    Pan, Qingqing
    Zhang, Xin
    Luo, Yaping
    Ma, Yanru
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : 164 - 166
12345